How doctors and patients view statins for primary prevention?
A new qualitative study offers insights into why so many people at low risk of heart disease are taking statins. More
A new qualitative study offers insights into why so many people at low risk of heart disease are taking statins. More
In a Washington Post op-ed, Paul Glastris and Phil Longman explain how our health care system makes it hard for hospitals to treat everyone regardless of race or need. More
Everyone has been talking about structural racism in criminal justice, but what about health care? In this latest edition of "Lown Hospitals Q&A," Shannon Brownlee and Vikas Saini discuss what the Lown Hospitals Index inclusivity metric shows about race and hospital access. More
A recent study in JAMA finds that nearly half of older adults are still screened for certain cancers above the recommended age. More
While everyone is focused on the current pandemic, how can we take actions now to reduce the threat of antibiotic resistance? More
Experts weigh in on the recently revealed price of Covid-19 drug remdesivir. More
Do the potential benefits of thrombolytic drugs for acute stroke outweigh the potential harms? In a guest blog, Drs W. Ken Milne and Daniel Fatovich examine this issue in light of new evidence. More
What are the top hospitals in the country doing to excel in all three categories on the Lown Hospitals Index? At a recent event hosted by the Lown Institute, Washington Monthly, and Open Markets Institute, the creators of the Lown Index and leaders of some of the winning hospitals discussed how hospitals can go from good to great. More
Members of the Lown Institute Working Group on Medication Overload gave a webinar presentation last week, which is available to watch now! More
State budgets have been squeezed over the past decade due in large part to the rising cost of health care, and Covid-19 is only making it worse. What can we do about this problem? More
The new Lown Institute Hospitals Index assesses civic leadership, value, and outcomes at US Hospitals. More
In the latest edition of the American Family Physician's Right Care Series, doctors and patients discuss the benefits and harms of taking anticoagulants for atrial fibrillation in older adults. More
A recent study from NEJM shows how inequality is “baked into the system” through clinical algorithms. More
How much should remdesivir cost? This question puts two drug-value organizations at odds. More
Watch the video of Shannon Brownlee and Jeanne Lenzer discussing pandemic misinformation in a Future Tense conversation. More
Even though we have saved lives by locking down, we still have to address the effects of this decision on our country's mental health. More
Visits from pharmaceutical sales reps haven't stopped during the pandemic--they've just moved online... More
From Dr. Ronald Adler, why we should be wary of the promises of GRAIL and other liquid biopsy companies. More
On the week of Dr. Bernard Lown's 99th birthday, we reflect on Dr. Lown's work connecting medical service to social activism, and understanding how this applies today. More
Racism must be destroyed for the health of us all, Dr. Vikas Saini writes, in response to recent police violence and protests. More